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a b s t r a c t
A Hoxd11/lacZ reporter, expressed with a Hoxd11-like axial expression pattern in transgenic mouse
embryos, is stimulated in tailbud fragments when cultured in presence of Gdf11, a TGF-β growth/
differentiation factor. The same construct is also stimulated by Gdf11 when transiently transfected into
cultures of HepG2 cells. Stimulation of the reporter in HepG2 cells is enhanced where it contains only the
332 bp Hoxd11 enhancer region VIII upstream or downstream of a luciferase or lacZ reporter. This
enhancer contains three elements conserved from ﬁsh to mice, one of which has the sequence of a
Smad3/4 binding element. Mutation of this motif inhibits the ability of Gdf11 to enhance reporter activity
in the HepG2 cell assay. Chromatin immunoprecipitation experiments show direct evidence of Smad2/3
protein binding to the Hoxd11 region VIII enhancer. The action of Gdf11 upon Hoxd11 in HepG2 cells is
inhibited, at least in part, by SIS3, a speciﬁc inhibitor of Smad3. SIS3 also produces partial inhibition of
Hoxd11/lacZ expression in cultured transgenic tailbuds, indicating that Smad3 may play a similar role in
the embryonic expression of Hoxd11. Transgenic mouse experiments show that the Smad binding motif is
essential for the axial expression of Hoxd11/lacZ reporter in the embryo tailbud, posterior mesoderm and
neurectoderm.
& 2013 Elsevier Inc. All rights reserved.
Introduction
The body plan of an animal is ﬁrst laid down in its embryo as a
pre-plan of developmental gene expression. This provides pat-
terns, in space and time, of transcription factors and signalling
molecules which mediate the speciﬁcation of cell fate. Patterns
of developmental gene expression are commonly regulated by
cis-regulatory elements, which include enhancers and silencers of
gene expression, and which are located outside the coding
sequence. Mutational changes in cis-regulatory elements of devel-
opmental genes have frequently mediated evolutionary changes in
body morphologies (Gaunt and Paul, 2012; Wittkopp and Kalay,
2012).
The Hoxd11 expression boundary plays a role in specifying
position of the lumbosacral junction along the vertebral column
(Davis and Capecchi, 1994). Hoxd11 function overlaps with that of
Hoxa11 and Hoxc11, and loss of all six alleles is required for
complete absence of sacral vertebrae (Wellik and Capecchi,
2003). A 332 bp Hoxd11 enhancer fragment (region VIII) (Gerard
et al., 1993; Gerard et al., 1997; Zakany et al., 1997) is located
downstream of the coding region, between Hoxd11 and Hoxd10.
Region VIII also serves as an enhancer for Hoxd10. Thus, embryos
homozygously deﬁcient for region VIII show posterior shift of
Hoxd11 and Hoxd10 expressions at 9 days gestation, and a
subsequent posterior shift of the lumbosacral junction (Zakany
et al., 1997). Surprisingly, expression boundaries of these two Hox
genes become normal by 10 days gestation.
The lumbosacral and thoracolumbar junctions are shifted poster-
iorly in Gdf11 knockout mice. This is due to posterior shifts within
paraxial mesoderm in the anterior expression limits of Hox genes
that pattern these regions (McPherron et al., 1999). These mice, with
dramatically elongated torsos, have been called dachshund mice
(Gad and Tam, 1999). It is unclear whether Gdf11 signalling acts
directly or indirectly upon the Hox genes. In a converse experimental
protocol, Gdf11 overexpression in chick embryo neural tissue results
in forward shift in the anterior expression limits of posteriorly-
expressed Hox genes (Liu, 2006). It appears that Gdf11 deﬁnes Hox
gene expression domains in the spinal cord in co-operation with FGF
(Liu, 2006; Liu et al., 2001). Together, the above studies indicate that
Gdf11 is able to regulate Hox expression boundary positions in both
paraxial mesoderm and neural tissue of the posterior embryo. The
hindlimb position of Gdf11 mutant mice is also shifted caudally
(McPherron et al., 1999). This position is set as part of the trunk-tail
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transition, co-ordinated by Gdf11 through an effect upon Isl1, rather
than upon Hox genes (Jurberg et al., 2013). Gdf11 is expressed in the
mouse embryo tailbud from about 8 to beyond 12.5 days (Gamer
et al., 1999; McPherron et al., 1999; Nakashima et al., 1999). The
Hoxd11 expression boundary becomes established in the tailbud
commencing at about 8.75 days (Izpisua-Belmonte et al., 1991).
Gdf11 is a member of the TGF-β family of growth factors (Feng
and Derynck, 2005; Massague et al., 2005; Shi and Massague,
2003; Wu and Hill, 2009). These bind to complexes of type I and
type II serine/threonine kinase receptors at the cell surface.
Predominantly, Gdf11's effect upon axial patterning utilizes the
type I receptor ALK5 (Andersson et al., 2006), and the type II
receptor Activin IIB (AcvrIIB), supplemented by AcvrIIA (Oh et al.,
2002). Knockout of either ALK5 or AcvrIIB results in axial defects
similar to Gdf11 knockout, with similar posterior shifts in a variety
of posteriorly-expressed Hox genes (Andersson et al., 2006;
Oh and Li, 1997; Oh et al., 2002).
Binding of TGF-ß ligand to the type II receptor recruits
and phosphorylates the type I receptor which then, in turn,
phosphorylates a cytoplasmic receptor-regulated Smad protein
(R-Smad). Alk5 phosphorylates the closely related Smad2 and Smad3
proteins (Andersson et al., 2006). Evidence has been presented that it
is Smad2 that mediates Gdf11 activation of Hox gene expression (Liu,
2006). Once activated, R-Smad complexes with Smad4, a Co-Smad, to
promote both nuclear accumulation and binding to speciﬁc enhancer
motifs (Smad binding elements or SBEs) for direct regulation of gene
expression. The Smad3 and Smad4 DNA binding element contains a
repeated AGAC sequence or its reverse complement, GTCT (Dennler
et al., 1998), with the palindrome GTCTAGAC as the optimal binding
sequence (Zawel et al., 1998). Smad2 itself normally lacks DNA
binding activity but may bind to this motif via its complex with
Smad4 (Feng and Derynck, 2005).
We now show that Gdf11 exerts a stimulatory effect upon a
Hoxd11/lacZ transgene expressed in the mouse embryo tailbud.
Hoxd11 reporters are also activated by Gdf11 in HepG2 cells, and
our studies indicate that this is a direct effect upon the region VIII
enhancer, operating via Smad signalling to a Smad binding
element. Transgenic mouse experiments show that the Smad
binding motif is also essential for the expression of Hoxd11/lacZ
reporter in the embryo tailbud.
Fig. 1. Hoxd11/lacZ transgene expression in embryos is stimulated by Gdf11. (A) Hoxd11/lacZ reporter constructs #1 and #2. In #2 a putative Smad binding motif (GTCTAGAC)
is mutated. Red box, Hoxd11 coding sequence; yellow box, Pst1/HindIII 332 bp fragment which contains the region VIII enhancer; N, Nsi1; S, Spe1; P, Pst1; H, HindIII; R, EcoR1;
X, Xba1. (B) A transgenic embryo line expresses construct #1 with an anterior axial boundary at the level of prevertebra 27 (v27), shown here at 10.25 days, and similar to
expression of the endogenous Hoxd11 gene. (C) Transgene expression commences in the tailbud at 9 days. (D) Tailbuds from 8.75 day transgenic embryos were bisected along
the lines shown in C. Left-hand fragments were cultured without, and right-hand fragments with, Gdf11 at 500 ng/ml for 16 h prior to staining for lacZ activity. Fragments are
viewed with anterior at the top. Stages of the embryos (8-somite to 14-somite) at the onset of culture are indicated. s, somite.
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Materials and methods
DNA constructs
The long Hoxd11/lacZ construct (construct #1) (Fig. 1A) contains
7.3 kb of mouse Hoxd11 DNA. It is similar to the Ns-E (Nsi1-EcoR1)
construct characterized earlier (Gerard et al., 1993), but differs as
follows: (i) lacZ/SV40 polyA is targeted in frame by recombineering
(Liu et al., 2003) into the second exon of Hoxd11 after nucleotide 90
of the homeobox; (ii) the 3′ end of the Hoxd11 second exon is
omitted, together with the ﬁrst 58 base pairs downstream of the
Hoxd11 stop codon; and (iii) a Spe1 site is introduced at the 3′ end
of lacZ. The latter allows replacement of Hoxd11 downstream
sequences with a corresponding 2.16 kb Spe1 fragment mutated
within the putative Smad binding motif of the Hoxd11 region VIII
(construct #2) (Fig. 1A). The mutation converts an Xba1 site into a
diagnostic Sal1 site. A short Hoxd11/lacZ construct (construct #3)
comprises the 332 bp Pst1/HindIII fragment that includes region
VIII, inverted relative to its normal orientation and followed in
series by SV40 minimal promoter, Kozak motif (GCCGCCACC), full
lacZ coding sequence and SV40 polyA (Fig. 2A). This construct is
comparable with the P-H/hs construct characterized earlier (Gerard
et al., 1993). All lacZ constructs were prepared in Bluescript KS-
(Stratagene). Construct #4, made in pGL3-promoter (Promega), was
similar to construct #3 but with luciferase as the reporter gene.
Various mutations were introduced by PCR into the conserved
motifs of region VIII as shown in Fig. 4. Region y (construct #6),
z (construct #7) and x (construct #8) mutations introduce diag-
nostic Sal1, EcoR1 or Spe1 sites. Further constructs were prepared
in which the Hoxd11 region VIII enhancer fragment is located in
both orientations upstream (constructs #4 and #9) and down-
stream (constructs #10 and #11) of luciferase in the pGL3-promoter
vector (Fig. 5A).
Hoxc11 299 bp fragment homologous to Hoxd11 region VIII was
isolated by PCR using primers CACCTTCATACTCCTTGGATG (5′) and
ATGTGGGGCAAAGGCATGATG (3′), and was then subcloned into
pGL3-promoter (Promega).
Expression constructs were made by cloning full-length coding
sequences of Cdx1, Hoxd11 or Hoxd10, with Kozak motif upstream
of ATG into a pCAGGS vector. Expression, driven by the constitutive
CAGGS promoter, was conﬁrmed in HepG2 cells by immunoﬂuor-
escence (not shown).
Fig. 2. Chemiluminescence to detect Gdf11 stimulation of Hoxd11 reporters. (A) Hoxd11 region VIII enhancer (yellow box) upstream of minimal SV40 promoter and either
lacZ (construct #3) or luciferase (luc) (construct #4) reporter genes. (B) Gdf11 stimulation in transgenic embryo tailbud or HepG2 cell monolayers. (C) Gdf11 stimulates
construct #4 in HepG2 but not P19 cells. In B and C, fold stimulation is the effect of 16 h (embryo) or 21 h (cell monolayer) incubation in Gdf11 (500 ng/ml for embryos;
50 ng/ml for cells) relative to no Gdf11. The embryo data compares activity in one half of a bisected embryo tailbud cultured with Gdf11, relative to the other half not given
Gdf11 (latter shown as dotted baseline) (cf. Fig. 1D). The cell culture data within each plot are from a single experiment, and each graph bar shows average values for three
replicate cultures given Gdf11, relative to the average for three replicates not given Gdf11 (latter shown as dotted baseline). Range bars are shown. (D) Dose-response curve
for Gdf11 stimulation of construct #4 in HepG2 cells.
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Reporter expression analysis in embryos and HepG2 cells
Transgenic mouse lines or transient transgenic embryos were
prepared by injecting the insert from the long Hoxd11/lacZ con-
structs #1 or #2 (Fig. 1A) into pronuclear mouse eggs, as described
earlier (Gaunt et al., 2003). Tailbuds from 8.75 day Hoxd11/lacZ
embryos were bisected using tungsten needles along the lines
shown in Fig. 1C, and then cultured in 50% D-MEM; 50% heat-
inactivated rat serum in 5% CO2; 95% air, at 37 1C for 16 h. Post-
culture embryo fragments were either stained for lacZ activity
(Hogan, 1994) or lysed for β-galactosidase chemiluminescence
assay (Applied Biosystems). Human Gdf11 and Wnt3a were from
R&D Systems; human FGF2 was from Invitrogen; all-trans retinoic
acid was from Sigma; and SIS3 inhibitor was from Calbiochem.
HepG2 cells, from ATCC, were cultured on gelatinized surfaces
in Dulbecco's MEM with glutamine and 10% foetal bovine serum.
Transfections and assays for β-galactosidase and luciferase were all
as described earlier (Gaunt and Paul, 2011). A stably-transgenic cell
line, HepG2/d11/lacZ, was prepared from HepG2 by transfection of
a linearized variant of construct #3 incorporating a neomycin
resistance cassette, followed by selection in 1.6 mg/ml G418. After
one week, and detachment of dead cells, G418 was reduced to
666 μg/ml for colony growth and subsequent maintenance of a
transgenic line.
Chromatin immunoprecipitation (ChIP) analysis
We used the Smad2/3 ExactaChIP kit (R&D Systems), which
includes an antibody that recognizes conserved epitopes in Smad2
and Smad3 proteins (Brown et al., 2007). HepG2/d11/lacZ trans-
genic cells at near-conﬂuence in a 90 mm dish were treated for
18 h with 50 ng/ml Gdf11. Medium was then replaced with PBS at
37 1C containing 1% formaldehyde. After 9 min, this was changed
to PBS containing 0.125 M glycine. After a further 5 min, cells were
scraped into PBS, pelleted, and then taken up in 300 μl of the
ExactaChIP lysis buffer containing protease inhibitors (Sigma
P8340). Chromatin was reduced to 200–1000 bp fragment length
by sonication in a Diagenode Bioruptor. Immunoprecipitation and
reverse crosslinking were as described in the ExactaChIP instruc-
tion manual, using streptavidin agarose beads (Sigma 85881) that
had been pre-blocked in 2% BSA for 1 h at 4 1C. PCR primers for
mouse Hoxd11 Region VIII were: CTGCAGTGCCCTTTATGTCACAG-
GAC (5′) and AAGCTTTGGCAATTTAAAAAATTC (3′), and for human
alpha1 actin were: GGCGTCATGGTCGGTATGGGT (5′) and CGCAC-
GATCTCGCGCTCAG (3′). Forty three cycles of PCR were used.
Results
Hoxd11/lacZ transgene expression in embryos is stimulated by Gdf11
Embryos of 10.25 days gestation from a mouse line transgenic
for the Hoxd11/lacZ construct #1 (Fig. 1A) show an anterior
boundary of expression at the level of presumptive prevertebra
27 (Fig. 1B). This is the same as that published for a similar Hoxd11/
lacZ transgene (Gerard et al., 1993), and similar to that of the
endogenous Hoxd11 gene (Izpisua-Belmonte et al., 1991). Hoxd11/
lacZ activity is ﬁrst seen at 9 days (Fig. 1C). Left- and right-hand
halves from the tailbuds of 8.75 day Hoxd11/lacZ embryos, pre-
pared by cuts along the lines shown in Fig. 1C, were cultured for
16 h in absence or presence of Gdf11, followed by lacZ staining.
The stimulatory effect of Gdf11 was clear by increased intensity
and spatial extent of lacZ staining (Fig. 1D). The enhanced staining
does not extend up to the anteriormost parts of the fragments,
suggesting that tissue becomes refractory to Gdf11 at a certain
distance from the posterior end. In chemiluminescence assays for
β-galactosidase activity we ﬁnd that Gdf11 protein stimulates, by
up to 7-fold, the expression of lacZ in bisected tailbuds of Hoxd11/
lacZ transgenic embryos (Fig. 2B).
Gdf11 stimulates Hoxd11 reporters in HepG2 cells
HepG2 cells are one of only a few cell culture types known to
respond to Gdf11 (Andersson et al., 2006). When these human
cells are transfected with the mouse Hoxd11/lacZ reporter con-
struct #1, we observe 1.5 fold stimulation by Gdf11 protein
(Fig. 2B). However, this increases to more than 5 fold (Fig. 2B)
when the 332 bp enhancer fragment region VIII (Gerard et al.,
1993) is used upstream of a minimal SV40 promoter and lacZ
(construct #3; Fig. 2A). This shortened construct, with enhancer
reversed relative to its endogenous orientation, is similar to one
known to be expressed with an approximately normal anterior
boundary in transgenic mouse embryos (Gerard et al., 1993).
Construct #4 is similar to construct #3 but uses luciferase as the
reporter. This is also stimulated in HepG2 cells, though not in P19
mouse embryonal carcinoma cells (Fig. 2C). Fig. 2D shows a dose
response curve for the action of Gdf11 upon expression of
construct #4 in HepG2 cells. Maximal effect is obtained at a dose
equal to, or greater than, 15 ng/ml.
Conserved regions in the Hoxd11 enhancer
When we examine the sequence of the 332 bp Hoxd11enhancer
fragment region VIII we ﬁnd three adjacent regions (x, y and z)
conserved from ﬁsh to mouse (Fig. 3A) (Gerard et al., 1997). Region
y contains the palindrome GTCTAGAC. This is remarkable because
this sequence has been identiﬁed as an optimal binding motif for
Smad3 and Smad4 proteins (Zawel et al., 1998), two components
in the TGF-β signalling pathway. Region z has the structure of a
conserved C/A/TATAAA motif, a recognition motif for Cdx proteins
(Margalit et al., 1993) which are known to affect Hox gene
expression. We ﬁnd conserved regions y and z at a corresponding
position downstream of Hoxc11 (Fig. 3B), though not of Hoxa11
(not shown). Interestingly, the Hoxc and d loci are thought to have
arisen by split of a common ancestral locus (Ravi et al., 2009).
Hoxc11, unlike Hoxd11, does not have conserved region x adjacent
to region y (Fig. 3).
Mutation of conserved regions affects response to Gdf11
In Fig. 4A and B we examine the effect of Gdf11 upon
expression of luciferase construct #4 in HepG2 cells, and show
the effects of mutations within the conserved motifs x, y and z of
the Hoxd11 enhancer. Wild-type enhancer (construct #4) is sti-
mulated more than 5 fold by Gdf11. In contrast, Gdf11 stimulation
is reduced when the Hoxd11 enhancer is absent (construct #5) or
is present with either region y (construct #6) or region x
(construct #8) mutated. Mutation within region z has no apparent
effect upon Gdf11 stimulation (construct #7).
Since conserved region z has the sequence of a Cdx protein
binding motif we tested construct #4 for a possible synergistic effect
of co-transfection with a Cdx1 expression construct. This did not
produce an obvious effect upon the level of Gdf11 stimulation
(Supplementary Fig. S2A). We also tested co-transfections with
expression constructs for two other homeobox genes: Hoxd10 and
Hoxd11. Here, we were testing for possible autoregulatory effects,
synergistic with Gdf11, of Hoxd10 and Hoxd11 proteins upon their
own enhancer. Neither Hoxd10 nor Hoxd11 produce a substantial
effect upon the level of Gdf11 stimulation (Supplementary Fig. S2A).
We also tested for possible synergistic effects of retinoic acid,
Wnt3a, and FGF, three signalling molecules known to be present in
the embryo tailbud. No substantial effects were seen upon Gdf11
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stimulation of construct #4 in HepG2 cells (Supplementary Fig.
S2B). This is in spite of the fact that HepG2 cells are known to
possess receptors for retinoic acid (Zhang et al., 2010), Wnt3a
(Ceballos et al., 2011), and FGF (Hu et al., 2012). The small but
reproducible suppression seen for FGF was also obtained at higher
doses (10, 50, and 100 ng/ml.) (not shown).
In these experiments we have examined transcription and
signalling factors for possible synergistic effects upon Gdf11
activation of the Hoxd11 region VIII enhancer. Synergistic effects
are described, for example, for the Cdx1 enhancer (Prinos et al.,
2001).The transcription and signalling factors tested alone, in
absence of Gdf11, also failed to activate construct #4 (not shown),
but our experiments do not rule out the possibilities that they may
act upon Hoxd11 outside the region VIII enhancer, or that there
may be other factors not tested here that act inside or outside the
enhancer.
Orientation of the Hoxd11 enhancer
In Fig. 5A and B, we examine the effect of the orientation of the
332 bp Hoxd11enhancer fragment in luciferase/minimal SV40
promoter constructs. All orientations provide stimulation. How-
ever, greatest stimulation is obtained where the enhancer, either
upstream (construct #4) or downstream (construct #11) of luci-
ferase, is in reverse orientation relative to its endogenous sense.
The full signiﬁcance of this remains unclear since our reporter
assays use circular plasmids. Interestingly, however, the Hoxd11en-
hancer upstream of lacZ had to be in reverse orientation in order
to produce a near-normal pattern of lacZ expression in lacZ
reporter transgenic embryos (Gerard et al., 1993).
An equivalent set of four constructs made with the Hoxc11
homologous region showed little evidence of activation by Gdf11
(Fig. 5B). This is perhaps not surprising since the 299 bp Hoxc11
fragment tested does not have the conserved region x (Fig. 3),
which is essential for Gdf11 activation of the Hoxd11 enhancer
(Fig. 4A and B).
Gdf11 stimulation is reduced by SIS3
SIS3, a speciﬁc inhibitor of Smad3, mediates its effect by dose-
dependent suppression of Smad3 phosphorylation, Smad3-DNA
binding, and interaction of Smad3 with Smad4. SIS3 does not
Fig. 3. Evolutionarily conserved motifs within Hoxd11 region VIII and Hoxc11. (A) Hoxd11. (B) Hoxc11. Numbers indicate base pairs downstream of the Hox11 gene stop codon.
x, y and z are regions of conserved sequence. Bars underline putative binding sites for Smad (region y) and Cdx (z) proteins. Sequences aligned using Vector NTI (Invitrogen).
Yellow highlight, fully conserved bases; blue, highly conserved. Accession numbers of sequences analyzed are given in Supplementary Fig. S1. Lizard, Anole Lizard; Tas. Devil,
Tasmanian Devil.
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Fig. 4. Effects of mutations upon Gdf11 activation of mouse Hoxd11 region VIII in
HepG2 cells. (A) construct #4 (Fig. 2) and its variants which either lack Hoxd11
enhancer (yellow box) or contain within it mutations introduced to evolutionarily
conserved regions x, y and z. Dashes indicate identity with the wild-type mouse
construct #4. (B) Effect of mutations upon Gdf11 activation of Hoxd11 region VIII in
HepG2 cells. In B, fold stimulation shows the effect of 21 h incubation in Gdf11
(50 ng/ml), relative to no Gdf11. Graph, range bars and baselines as in Fig. 2.
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affect phosphorylation of Smad2, or the expression of Smad4
(Jinnin et al., 2006). In HepG2 cells, Gdf11 activation of Hoxd11/
luciferase reporter construct #4 is progressively inhibited by
increasing doses of SIS3 (Fig. 6A). This suggests that it is Smad3
that, at least in part, mediates the effect of Gdf11 upon Hoxd11 in
HepG2 cells.
To test for a role of Smad3 in the embryo, we bisected 8.75 day
Hoxd11/lacZ transgenic embryo tailbuds and then compared left
and right-hand fragments after culture for 16 h in either SIS3
inhibitor or DMSO control. Fragments cultured in SIS3 were
reduced in lacZ expression as determined by lacZ staining, though
inhibition was incomplete, even at 20 μM (Fig. 6B). This suggests
that at least part of the Gdf11 effect upon embryonic Hoxd11
expression may be mediated by Smad3.
Chromatin immunoprecipitation (ChIP) shows binding of Smad2/3
protein to the Hoxd11 region VIII enhancer
To test directly for Smad protein binding to the Hoxd11 region
VIII enhancer we carried out ChIP experiments using an antibody
which binds to conserved epitopes in Smad2 and Smad3 proteins.
HepG2 cells exposed to Gdf11 after transient transfection at near
conﬂuence of Hoxd11/lacZ reporter construct #3 showed fewer
than 10% transfected cells (Fig. 7A). For the ChIP analysis, we
therefore also used a HepG2/d11/lacZ transgenic line which, upon
exposure to Gdf11, expresses lacZ in 100% of the cells (Fig. 7B). This
line expresses lower levels of lacZ in absence of Gdf11 (Fig. 7C),
likely due to endogenous Smad activity upon the Hoxd11 region
VIII transgene. After Gdf11 exposure, HepG2/d11/lacZ cell chroma-
tin contained, prior to immunoprecipitation, readily detected
mouse Hoxd11 region VIII and human alpha1 actin DNAs, but
Smad2/3 antibody precipitated only the former, indicating that
Smad2/3 protein had been bound in chromatin to Hoxd11 region
VIII (Fig. 7D). After use of a similar number of PCR cycles (forty
three) we did not obtain positive ChIP results from transiently
transfected HepG2 cells (not shown), presumably due to the low
transfection efﬁciency (Fig. 7A).
A Hoxd11 transgene with mutation in the Smad binding motif is not
expressed in the embryo tailbud
We wished to test whether the Smad binding motif in region
VIII enhancer is essential for the expression of Hoxd11/lacZ con-
struct #1 transgene in the embryo tailbud, and hence in the
posterior mesoderm and neurectoderm (Fig. 8A–E). For this, we
prepared transgenic embryos expressing construct #2 (Fig. 8F–J).
Construct #2 differs from construct #1 only by mutation in the
Fig. 5. Effects of position and orientation of the Hoxd11 region VIII enhancer. (A)
Hoxd11 region VIII enhancer (yellow box) in various positions relative to SV40
minimal promoter/luciferase. (B) Effects of enhancer orientation and position upon
Gdf11 stimulation of the Hoxd11 constructs, relative to each other and also to
equivalent Hoxc11 constructs. Culture conditions, graphs, range bars and baseline as
in Fig. 2.
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Fig. 6. Effect of speciﬁc inhibitor of Smad3 (SIS3) upon Hoxd11 reporter expressions in HepG2 cells and embryo fragments. (A) Gdf11 stimulation of construct #4 is reduced
by SIS3. The data are from a single experiment, and each graph bar shows average values for three replicate cultures given Gdf11, relative to the average for three replicates
not given Gdf11 (latter shown as dotted baseline). Range bars are shown. All cultures received equal amounts of DMSO solvent. (B) Expression of Hoxd11/lacZ transgene in
bisected 8.75 day embryo tailbud fragments, cultured without added Gdf11, is reduced by SIS3 (20 mM).
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putative Smad binding motif (conserved region y) of the Hoxd11
region VIII enhancer (Figs. 1A and 3). In Fig. 8G–I, we show three
independently-derived transient transgenic embryos for construct #2.
None of these show the axial expression of lacZ in the tailbud,
posterior mesoderm and neurectoderm as seen for construct #1at
equivalent stages of development (Fig. 8B–D). Instead, expression of
1 2 3 4 5 6
1018
298
220
510
bp
Fig. 7. Smad2/3 binding to the Hoxd11 region VIII enhancer detected by chromatin immunoprecipitation (ChIP). (A) HepG2 cells transiently transfected with Hoxd11/lacZ
construct #3, and treated for 18 h with Gdf11 (50 ng/ml) show fewer than 10% expressing cells (stained blue). (B) Cells stably transgenic for construct #3 (HepG2/d11/lacZ
cells) show 100% lacZ positive cells after Gdf11 treatment, and lower levels of lacZ expression without Gdf11 (C). (D) ChIP analysis on transgenic HepG2/d11/lacZ cells treated
with Gdf11. Lane 1, size markers (bp, base pairs); lane 2: chromatin prior to ChIP, sonicated to 200–1000 bp; lane 3: Hoxd11 region VIII (332 bp) and alpha1 actin (713 bp)
DNAs ampliﬁed by PCR from pre-ChIP chromatin; lane 4: Hoxd11 but not alpha1 actin DNA ampliﬁed from chromatin precipitated by anti-Smad2/3 antibody; lanes 5,6:
reduced Hoxd11 ampliﬁcation product after precipitation by normal goat IgG (lane 5) or no IgG (lane 6).
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Fig. 8. Axial (tailbud) expression of Hoxd11/lacZ transgene in embryos is inhibited by mutation within the putative Smad binding motif. (A–E) Wild-type (construct #1)
transgene expression in embryos at 10 to 16 days post coitum. (F–J) Mutant (construct #2) transgene expression in embryos at equivalent stages to those above. ov, otic
vesicle; hg, hind gut; u, umbilicus. Arrows in G–I indicate other sites of ectopic (non-Hoxd11-like) expression.
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construct #2 is expressed variably and ectopically between embryos in
the head, apical ectodermal ridge, anterior neural tube, eye, mouth,
and is also expressed at some sites shared with construct #1(hindgut
and umbilicus). To examine a more complete range of embryonic
stages we also made a transgenic line of mice that expresses construct
#2 (Fig. 8F and J). At no stage from 10d (Fig. 8F) to 16d (Fig. 8J) does
this line show Hoxd11-like expression in the tailbud. We conclude that
the Smad binding motif in region VIII enhancer is essential at all stages
from 10 to 16 days for axial expression of construct #1 in the tailbud,
posterior mesoderm and neurectoderm, and that this is likely
mediated by Gdf11/Smad signalling. We cannot rule out the possibility
that additional Hoxd11 Smad response elements might be located
outside the limits of constructs #1 and #2. Gerard et al. (1993)
examined embryos transiently transgenic for Hoxd11/lacZ constructs
that lacked both the region VIII enhancer and additional downstream
sequence. They detected no tailbud expression at 10 days, or later,
consistent with our ﬁndings.
Discussion
Cis enhancers regulate axial Hox gene expression boundaries
Hox expression boundaries along the embryonic axis are estab-
lished, at least to an important extent, as a result of regulatory factors
interacting with cis enhancers located in and around the Hox genes.
Thus, a near-normal pattern of expression has often been obtained
simply from a Hox/lacZ transgene randomly integrated into the
genome, provided it contains the appropriate cis elements. A good
example here is given by Hoxd11/lacZ transgenes that include the
region VIII enhancer (Gerard et al., 1993) (Figs. 1B and C, 8A–E). Factors
that regulate Hox gene cis enhancers, directly or indirectly, may be
soluble, diffusible substances such as retinoic acid, FGF and Gdf11 (Bel-
Vialar et al., 2002; Gad and Tam, 1999), or intracellular transcription
factors such as Cdx proteins (Charite et al., 1998; Gaunt et al., 2004).
In theory, such factors could affect the position of a Hox
expression boundary along the axis either by affecting the initial
timing of gene activation (temporal collinearity model) (Izpisua-
Belmonte et al., 1991), or by their distribution being uneven
(possibly graded) along the embryo (morphogen model). Gdf11, a
TGF-β ligand, could be a morphogen for specifying expression
domains of posteriorly-expressed Hox genes (McPherron et al.,
1999). The known vertebrate morphogens activin and nodal both
operate via TGF-β signalling. A model has been presented in which
an anteroposterior gradient of Gdf11, operating in conjunction
with an FGF gradient, speciﬁes the anterior limits of Hox expres-
sion in the developing spinal cord (Liu, 2006). The implication
here is that Hox expression boundaries form at speciﬁc threshold
concentrations of Gdf11. Various other roles of TGF-β ligands are
known to depend critically upon the concentration to which
responding cells are exposed (Guzman-Ayala et al., 2009).
The Gdf11/Hoxd11activation pathway in embryos and HepG2 cells
The position of the lumbosacral junction, regulated in part by
the Hoxd11 expression boundary (Davis and Capecchi, 1994;
Gerard et al., 1997; Zakany et al., 1997), is shifted posteriorly in
Gdf11 knockout mice (McPherron et al., 1999). Consistent with this
we show that expression of a Hoxd11/lacZ transgene is enhanced,
and its domain expanded anteriorly by addition of Gdf11 to
cultured embryo tailbud fragments.
Using HepG2 cells, we present the ﬁrst evidence that Gdf11/Smad
signalling acts directly upon a Hox gene enhancer, namely region VIII
of Hoxd11 (Gerard et al., 1993). Chromatin immunoprecipitation
experiments showed binding of Smad2/3 protein to the region VIII
enhancer in HepG2 cells transgenic for a region VIII/lacZ transgene.
Two conserved elements are shown to be essential for function: a
motif with the sequence (GTCTAGAC) of a Smad binding element and
an adjacent, upstream motif. The function of the upstream motif is
unknown. One possibility is that it is a transcription factor binding site,
and it is known that Smad binding elements commonly lie adjacent to
motifs bound by cell-type speciﬁc transcription factors (Mullen et al.,
2011). It is the binding of such a transcription factor that renders the
nearby Smadmotif functional (Mullen et al., 2011). Mullen et al. (2011)
suggest that this is mediated by opening of chromatin structure,
although the applicability of this in our studies with transiently
transfected plasmids is unclear. Apart from Hoxd11, several other
posteriorly-expressed Hox genes are responsive to disruption in Gdf11
signalling (Andersson et al., 2006; McPherron et al., 1999; Oh and Li,
1997). It therefore seems likely that our Gdf11 assays will be applicable
to other Hox gene enhancers. A homologous region including a
putative Smad binding motif downstream of Hoxc11 did not respond
to Gdf11, possibly due to absence of the adjacent upstreammotif in the
short (299 bp) fragment that we tested. Hoxc11 expression has
speciﬁcally been shown to be shifted posteriorly in embryos lacking
Gdf11 (McPherron et al., 1999) or its AcvrIIB receptor (Oh and Li, 1997).
The Gdf11 pathway in the embryonic axis operates through
Alk5 and, as such, is expected to activate both Smad2 and Smad3
(Andersson et al., 2006). Both of these Smads are expressed
together in most of the tissues of the embryo (Dunn et al., 2004;
Tremblay et al., 2000). Liu (2006) presented evidence that the
effect of Gdf11 upon axial patterning can be mediated by Smad2.
Thus, a constitutively activated form of Smad2 introduced by
electroporation in chick embryos was able to induce Hoxc9 and
Hoxc10 in spinal cord. Liu's ﬁnding does not, however, rule out a
role for Smad3 and we found that SIS3, a speciﬁc inhibitor of
Smad3 (Jinnin et al., 2006), is able both to inhibit the effect of
Gdf11 upon Hoxd11 reporter in HepG2 cells, and to partially
suppress Hoxd11/lacZ transgene expression in cultured tailbud
fragments. It is known that Smad2 and Smad3 operate together
in other TGF-βmediated events in the embryo, for example activin
and nodal regulated signalling in mesoderm formation and pat-
terning (Dunn et al., 2004). Smad knockout mice do not resolve
the relative importance of Smad2 and Smad3 in Hox patterning.
Smad2þ / mice are phenotypically normal, while homozygous
mutants die at 8.5 to 9.5 days (Waldrip et al., 1998). Smad3 /
mice are viable and not reported to have homeotic defects (Datto
et al., 1999), but it remains possible that Smad2 and Smad3
regulate Hox genes with functional redundancy, as they are known
to do at other loci (Dunn et al., 2004; Takimoto et al., 2010).
While a Hoxd11/lacZ reporter containing 7.3 kb of Hox DNA was
expressed with a Hoxd11-like axial pattern in transgenic mice, this
was inhibited by mutation within the putative Smad binding
motif, GTCTAGAC, of the region VIII enhancer. This shows that all
in vivo activation of the Hoxd11 transgene operates through this
motif, but it does not rule out the possibility that Smad binding
elements more distant from Hoxd11might also regulate expression
of the endogenous gene. Mouse embryos knocked out for region
VIII show posterior shift in endogenous Hoxd11 expression at
9 days, but by 10 days the boundary has assumed its normal
position (Zakany et al., 1997). This suggests a second level of
control upon the Hoxd11 expression domain. This control might lie
outside the limits of our Hoxd11/lacZ constructs since we did not
see any axial expression of lacZ in 10 to 16 day transgenic embryos
expressing the Smad motif-deﬁcient construct.
Conclusions
Gdf11 exerts a stimulatory effect upon a Hoxd11/lacZ transgene
expressed in the mouse embryo tailbud, and Hoxd11 reporters are
also activated by Gdf11 in cultured HepG2 cells. We show that
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stimulation in HepG2 cells occurs via the Hoxd11 region VIII
enhancer. Both a Smad binding motif and an adjacent conserved
element are essential for this function, and chromatin immuno-
precipitation reveals Smad2/3 protein bound to the activated
enhancer. Transgenic mouse experiments show that the Smad
binding motif is also essential for axial expression of Hoxd11/lacZ
reporter in the embryo. Our ﬁndings provide the ﬁrst evidence
that Hox genes may be directly regulated by Gdf11/Smad signal-
ling in the embryo tailbud.
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